SAN DIEGO--(BUSINESS WIRE)--Today, Cardea Bio, Inc. - the world’s only mass producer of biocompatible semiconductors - announced a significant milestone with the launch of CRISPR QC Inc. as a separate ...
SAN DIEGO, June 14, 2022 /PRNewswire/ -- Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics at Keck Graduate Institute (KGI) and Chief Scientific Officer of Cardea Bio, ...
Acquisition to deliver significant progress in manufacturing and technology capabilities, and will further propel CRISPR QC's success in the fast growing gene editing market. SAN DIEGO--(BUSINESS WIRE ...
SAN DIEGO, Aug. 25, 2022 /PRNewswire/ -- As part of the Semiconductor Research Corporation (SRC) being selected by NIST's Advanced Manufacturing Office to define the future of Microelectronics and ...
SAN DIEGO, April 27, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their continued success to secure broad intellectual property (IP) ...
SAN DIEGO, Aug. 16, 2022 /PRNewswire/ --Since its founding in late 2013, Cardea's scientists have been pioneering the development of the world's first mass produced biocompatible semiconductor - the ...
San Diego-based Cardea Bio, which is developing "electronic nose" technology, says it has received a $1.1M grant from the Bill & Melinda Gates Foundation. According to the company, it will use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results